SCHEMBL9998014

SCHEMBL9998014

CCCc1ccc(C=C(C(C)C)C(OC(C)=O)OC(C)=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.39
ACACB O00763 3/20 0.37
ACACA Q13085 1/20 0.37
ALDH1A1 P00352 3/20 0.36
PLK1 P53350 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
MCL1 Q07820 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997406 0.92 ALDH1A1 (0.41) THRBALDH1A1PLK1MAPTKDM4E
SCHEMBL9998606 0.91 THRB (0.43) THRBALDH1A1KMT2APLA2G1BATG4B
SCHEMBL9997993 0.90 TNNC1 (0.44) THRBALDH1A1KMT2APLA2G1BATG4B
SCHEMBL9997446 0.90 TNNC1 (0.44) THRBALDH1A1KMT2APLA2G1BATG4B
SCHEMBL9997947 0.90 TNNC1 (0.44) THRBALDH1A1KMT2APLA2G1BATG4B
SCHEMBL9997835 0.90 TNNC1 (0.44) THRBALDH1A1KMT2APLA2G1BATG4B
SCHEMBL9998411 0.90 TNNC1 (0.44) THRBALDH1A1KMT2APLA2G1BATG4B
SCHEMBL9997930 0.89 MAOB (0.38) ACACBALDH1A1MAPTKDM4ELMNA
SCHEMBL9997668 0.86 THRB (0.41) THRBACACBACACAALDH1A1PLK1
SCHEMBL9997671 0.86 THRB (0.41) THRBACACBACACAALDH1A1PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 THRB 926/4885ACACB 1423/4885ACACA 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.